Skip To Main Content
Xiaochen Yin on Muck Rack

Xiaochen Yin

As seen in: BioRxiv, Cell Reports Medicine, medRxiv, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiaochen

Contact Xiaochen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Microbiome and Cancer Immunotherapies

|
By Haoyan Chen, Laurence Zitvogel, Zhi Peng, Xiaochen Yin
| Texas Medical Center
Home > UTHealth > GSBS > Student and Faculty Publications > 1613 Student and Faculty Publications Cell Reports Medicine Humans, Microbiota, Immunotherapy, Stomach Neoplasms DOWNLOADS Included in Bioinformatics Commons, Biomedical Informatics Commons, Medical Sciences Commons, Oncology Commons COinS
Open in Who Shared Issue with article?

Fecal microbiota transplantation promotes immunotherapy sensitivity in refractory gastrointestinal cancer patients: open label, single-arm, single center, phase 1 study

|
By Yifan Zhang, Xiaomin Xu, Shulin Wang, Xiaochen Yin
| medRxiv
The authors have declared no competing interest. NCT04130763 This study was funded by Key Program of Beijing Natural Science Foundation, National Natural Science Foundation of China, Beijing Medical Research Institute, Xbiome. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (20) Issue with article?

Microbiome and cancer immunotherapies

|
By Haoyan Chen, Laurence Zitvogel, Zhi Peng, Xiaochen Yin
| Cell Reports Medicine Verified
Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients’ care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.
Open in Who Shared Issue with article?
See all 5 articles